Showing results (81-90 of 115) with videos related to
Sort By:
Pageof 12
Neurobiology of Disease|September 21, 2017
Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndromeChao-Yin Chen, Jacopo Di Lucente, Yen-Chu Lin, et al.Annals of Clinical and Translational Neurology|June 8, 2017
First-in-man allopregnanolone use in super-refractory status epilepticusHenrikas Vaitkevicius, Aatif M Husain, Eric S Rosenthal, et al.Human Molecular Genetics|April 3, 2012
Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanoloneZhengyu Cao, Susan Hulsizer, Flora Tassone, et al.The Lancet. Neurology|November 20, 2015
Is a separate monotherapy indication warranted for antiepileptic drugs?Scott Mintzer, Jacqueline A French, Emilio Perucca, et al.Annals of Neurology|November 4, 2014
Pediatric super-refractory status epilepticus treated with allopregnanoloneEileen Broomall, JoAnne E Natale, Michele Grimason, et al.Annals of the New York Academy of Sciences|July 29, 2016
Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agentsIsaac N Pessah, Michael A Rogawski, Daniel J Tancredi, et al.Epilepsy Research|July 4, 2006
Termination of epileptiform activity by cooling in rat hippocampal slice epilepsy modelsGholam K Motamedi, Patricia Salazar, Eric L Smith, et al.Epilepsy Currents|January 23, 2020
Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side EffectsStephen F Traynelis, Dennis Dlugos, David Henshall, et al.Plos One|June 4, 2015
Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's diseaseRonald W Irwin, Christine M Solinsky, Carlos M Loya, et al.Epilepsia|August 6, 2013
Epilepsy therapy development: technical and methodologic issues in studies with animal modelsAristea S Galanopoulou, Merab Kokaia, Jeffrey A Loeb, et al.Pageof 12